Engineered Microorganisms for Advancing Tumor Therapy
Advanced Materials · 2024
DOI: 10.1002/adma.202313389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2024. Verfasst von Jinxuan Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 293 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Nanjing Medical Science and Technique Development Foundation.
Abstract (Originalsprache)
Engineered microorganisms have attracted significant interest as a unique therapeutic platform in tumor treatment. Compared with conventional cancer treatment strategies, engineering microorganism‐based systems provide various distinct advantages, such as the intrinsic capability in targeting tumors, their inherent immunogenicity, in situ production of antitumor agents, and multiple synergistic functions to fight against tumors. Herein, the design, preparation, and application of the engineered microorganisms for advanced tumor therapy are thoroughly reviewed. This review presents a comprehensive survey of innovative tumor therapeutic strategies based on a series of representative engineered microorganisms, including bacteria, viruses, microalgae, and fungi. Specifically, it offers extensive analyses of the design principles, engineering strategies, and tumor therapeutic mechanisms, as well as the advantages and limitations of different engineered microorganism‐based systems. Finally, the current challenges and future research prospects in this field, which can inspire new ideas for the design of creative tumor therapy paradigms utilizing engineered microorganisms and facilitate their clinical applications, are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325035, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
- National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi, 530021, China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, China.
ORCID-Profile: Jinxuan Jia, Yuanjin Zhao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Nanjing Medical Science and Technique Development Foundation
- Clinical Trials from Nanjing Drum Tower Hospital
Zitieren
APA
Jia, J., Wang, X., Lin, X., & Zhao, Y. (2024). Engineered Microorganisms for Advancing Tumor Therapy. Advanced Materials. https://doi.org/10.1002/adma.202313389
Vancouver
Jia J, Wang X, Lin X, Zhao Y. Engineered Microorganisms for Advancing Tumor Therapy. Advanced Materials. 2024. doi:10.1002/adma.202313389
BibTeX
@article{Jia2024,
author = {Jia, Jinxuan and Wang, Xiaocheng and Lin, Xiang and Zhao, Yuanjin},
title = {Engineered Microorganisms for Advancing Tumor Therapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202313389}
}
EUVIMED